Red cell distribution width as a bleeding predictor after percutaneous coronary intervention

American Heart Journal

Volumn 166, Issue 1, 2013, Pages 104-109

  Fatemi, Omid ^a   Torguson, Rebecca ^a   Chen, Fang ^a   Ahmad, Soha ^a   Badr, Salem ^a   Satler, Lowell F ^a   Pichard, Augusto D ^a   Kleiman, Neal S ^b   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CELL COUNT; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE PARAMETERS; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RED CELL DISTRIBUTION WIDTH; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY; SCORING SYSTEM;

AGED; CORONARY ARTERY DISEASE; ERYTHROCYTE COUNT; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS;

EID: 84879782168     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.04.006     Document Type: Article

References (31)

1. S.K. Zalawadiya, V. Veeranna, and A. Niraj Red cell distribution width and risk of coronary heart disease events Am J Cardiol 106 2010 988 993
2. K.V. Patel, L. Ferrucci, and W.B. Ershler Red blood cell distribution width and the risk of death in middle-aged and older adults Arch Intern Med 169 2009 515 523
3. M. Tonelli, F. Sacks, and M. Arnold Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease Circulation 117 2008 163 168
4. O. Fatemi, J. Paranilam, and A. Rainow Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention J Thromb Thrombolysis 35 1 2013 57 64
5. S. Poludasu, J.D. Marmur, and J. Weedon Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention Thromb Haemost 102 2009 581 587
6. R.D. Semba, K.V. Patel, and L. Ferrucci Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I Clin Nutr 29 2010 600 604
7. M. Montagnana, G. Cervellin, and T. Meschi The role of red blood cell distribution width in cardiovascular and thrombotic disorders Clin Chem Lab Med 50 2011 635 641
8. K.V. Patel, R.D. Semba, and L. Ferrucci Red cell distribution width and mortality in older adults: a meta-analysis J Gerontol A Biol Sci Med Sci 65 2010 258 265
9. S.K. Mehta, A.D. Frutkin, and J.B. Lindsey National Cardiovascular Data Registry. Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry Circ Cardiovasc Interv 2 2009 222 229
10. D.J. Cohen, A.M. Lincoff, and T.A. Lavelle Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial J Am Coll Cardiol 44 2004 1792 1800
11. M. Moscucci, K.A. Fox, and C.P. Cannon Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
12. H.D. Aronow, P.A. Peyser, and K.A. Eagle Predictors of length of stay after coronary stenting Am Heart J 142 2001 799 805
13. B.J. Doyle, H.H. Ting, and M.R. Bell Major femoral bleeding complications after percutaneous coronary intervention. Incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to2005 J Am Coll Cardiol Intv 1 2008 202 209
14. M.A. Gaglia, R. Torguson, and M.A. Gonzalez Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention Am J Cardiol 106 2010 1069 1074
15. A.M. Lincoff, J.A. Bittl, and R.A. Harrington Bivalrudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: the REPLACE-2 randomized trial JAMA 289 2003 853 863
16. G.W. Stone, B.T. McLaurin, and D.A. Cox Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
17. M.J. Pencina, R.B. D'Agostino Sr., and E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
18. J.R. Buchler, E.E. Ribeiro, and J.L. Falcao A randomized trial of 5versus 7 French guiding catheters for transfemoral percutaneous coronary stent implantation J Interv Cardiol 21 2008 50 55
19. S.V. Rao, F.S. Ou, and T.Y. Wang Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention. A report from the National Cardiovascular Data Registry J Am Coll Cardiol Intv 1 2008 379 386
20. E. Cavusoglu, V. Chopra, and A. Gupta Relation between red blood cell distribution width (RDW) and all-cause mortality at 2 years in an unselected population referred for coronary angiography Int J Cardiol 141 2010 141 146
21. S. Dabbah, H. Hammerman, and W. Markiewicz Relation between red cell distribution width and clinical outcomes after acute myocardial infarction Am J Cardiol 105 2010 312 317
22. G. Lippi, G. Targher, and M. Montagnana Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients Arch Pathol Lab Med 133 2009 628 632
23. L.W. Klein, and C. Arrieta-Garcia Is patient frailty the unmeasured confounder that connects subacute stent thrombosis with increased periprocedural bleeding and increased mortality? J Am Coll Cardiol 59 2012 1760 1762
24. J. Walston, M.A. McBurnie, and A. Newman Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study Arch Intern Med 162 2002 2333 2341
25. D. Mari, P.M. Mannucci, and R. Coppola Hypercoagulability in centenarians: the paradox of successful aging Blood 85 1995 3144 3149
26. E.G. Lakatta Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging Circulation 107 2003 490 497
27. L.S. Acree, L.A. Killewich, and C. Aston Age-related influences on markers of inflammation and fibrinolysis [abstract] FASEB J 923 2008 7
28. C.J. Knight, M. Panesar, and C. Wright Altered platelet function detected by flow cytometry. Effects of coronary artery disease and age Arterioscler Thromb Vasc Biol 17 1997 2044 2053
29. W.B. Batchelor, K.J. Anstrom, and L.H. Muhlbaier Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7472 octogenarians J Am Coll Cardiol 36 2000 723 730
30. Y. Wen High red blood cell distribution width is closely associated with risk of carotid artery atherosclerosis in patients with hypertension Exp Clin Cardiol 15 2010 37 40
31. Z. Ye, C. Smith, and I.J. Kullo Usefulness of red cell distribution width to predict mortality in patients with peripheral artery disease Am J Cardiol 107 2011 1241 1245